What is Neurontin
Simply put Neurontin prevents the nerves from overfeeling. Overreaction by the nerve cells in the form of feeling pain in response to what should be normal stimulus. Neurontin also prevents an exaggerated response by the nerves to a painful stimulus.

About the Deceptive Marketing
Pfizer, which acquired Parke-Davis in 2000, created a marketing strategy to promote Neurontin for unapproved uses such as:

• Chronic Pain
• Bipolar Disorder
• Migraines
• Pain Syndromes
• Post-Hepatic Neuralgia
• Essential Tremor Periodic Limb Movement
• Treatment of Epilepsy
• Reflex Sympathetic Dystrophy
• Attention Deficit Disorder
• Drug and Alcohol Withdrawal Seizures
• Restless Leg Syndrome
• Trigeminal Neuralgia
• Migraine
• Peripheral Neuropathy
• Diabetic Neuropathy

While it is not illegal for a doctor to prescribe a medication for an unapproved or untested condition, it is illegal for a drug company to market a drug for an unapproved or untested condition.

In 1995 Parke-Davis decided that it did not want test the drug through clinical trials that the FDA requires to approve new uses for a drug. Instead the company created an illegal promotional campaign by giving doctors "medical education" or "consulting" cash fees that included illegal kickbacks to doctors, including trips to Puerto Rico and tickets to the 1996 Summer Olympics, to prescribe what has become the nation's best-selling anticonvulsant, Neurontin.

In July, 2003, Dateline NBC aired a story in which a corporate whistleblower exposed how Pfizer, "deliberately distorted information," about Neurontin.

In its year-long investigation, Dateline interviewed a former Parke-Davis scientist who alleges company officials encouraged him to persuade physicians to prescribe Neurontin for a number of disorders even though there was minimal preliminary data indicating that Neurontin could help patients with those diseases.

How Can We Help?
If you have been injured by the drug Neurontin, then you may be entitled to compensation. The law firm of Kelley/Uustal is handling Neurontin cases.